Immediate Postoperative Pelvic Organ Prolapse Quantification Measures and 2-Year Risk of Prolapse Recurrence.
Female
Follow-Up Studies
Gynecologic Surgical Procedures
/ adverse effects
Humans
Middle Aged
Outcome and Process Assessment, Health Care
Pelvic Floor
/ surgery
Pelvic Organ Prolapse
/ diagnosis
Postoperative Complications
/ diagnosis
Prognosis
Plastic Surgery Procedures
/ adverse effects
Recurrence
Risk Adjustment
/ methods
Severity of Illness Index
Sexual Dysfunction, Physiological
/ diagnosis
Symptom Assessment
/ methods
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
15
9
2020
medline:
1
12
2020
entrez:
14
9
2020
Statut:
ppublish
Résumé
To assess whether resting genital hiatus, perineal body, and total vaginal length measured intraoperatively at the conclusion of surgery are associated with prolapse recurrence 2 years after native tissue pelvic organ prolapse reconstruction. This ancillary analysis of the OPTIMAL (Operations and Pelvic Muscle Training in the Management of Apical Support Loss) trial included women who had an immediate postoperative pelvic organ prolapse quantification (POP-Q) examination and 2-year follow-up. Primary outcome was bothersome bulge symptoms. Secondary outcomes were anatomic failure, surgical failure (either anatomic failure or bothersome bulge symptoms), and sexual function. Descriptive statistics assessed relationships between postprocedure POP-Q measures and these four outcomes. Multivariable models were fit to the data to control for baseline differences in bivariate comparisons. Receiver operating characteristic curves were generated to identify an optimal genital hiatus cut point associated with bothersome bulge, and this threshold was explored. This analysis included 368 participants. Bivariate analyses identified age, body mass index, vaginal deliveries, baseline genital hiatus, perineal body, and advanced POP-Q stage (3 or higher vs 2) as clinically relevant variables to include in multivariable models. After adjusting for these variables, the association between immediate postoperative genital hiatus and bothersome bulge (adjusted odds ratio [aOR] 1.4; 95% CI 0.9-2.1) was not significant at the P<.05 level; however, immediate postoperative genital hiatus was associated with anatomic (aOR 1.6; 95% CI 1.1-2.3) and surgical failure (aOR 1.5; 95% CI 1.0-2.1). Immediate postoperative genital hiatus of 3.5 cm was the selected cutoff (area under the curve 0.58, 95% CI 0.50-0.66 from the bothersome bulge model). Women with genital hiatus 3.5 cm or greater were more likely to have anatomic and surgical failures at 2 years. No POP-Q measures were correlated with 2-year sexual function. A larger immediate postoperative genital hiatus measurement of 3.5 cm or greater is not associated with bothersome bulge symptoms or sexual dysfunction but is associated with anatomic and surgical failures 2 years after native tissue vaginal reconstructive surgery.
Identifiants
pubmed: 32925609
doi: 10.1097/AOG.0000000000004043
pmc: PMC7526641
mid: NIHMS1603878
pii: 00006250-202010000-00023
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
792-801Subventions
Organisme : NICHD NIH HHS
ID : U10 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041267
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD054241
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069013
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054214
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069006
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD069010
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD041261
Pays : United States
Organisme : NICHD NIH HHS
ID : U24 HD069031
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD054241
Pays : United States
Références
Obstet Gynecol. 2018 Jun;131(6):1137-1144
pubmed: 29742664
Female Pelvic Med Reconstr Surg. 2019 May/Jun;25(3):226-230
pubmed: 29210807
Int Urogynecol J. 2011 Jul;22(7):799-804
pubmed: 21416284
Am J Obstet Gynecol. 2020 Feb;222(2):161.e1-161.e8
pubmed: 31449806
Female Pelvic Med Reconstr Surg. 2014 Jan-Feb;20(1):27-32
pubmed: 24368485
Am J Obstet Gynecol. 2006 Nov;195(5):e1-4
pubmed: 17074540
Am J Obstet Gynecol. 2016 Jun;214(6):718.e1-8
pubmed: 26719211
Am J Obstet Gynecol. 1993 Aug;169(2 Pt 1):284-7; discussion 287-8
pubmed: 8362937
Int J Gynaecol Obstet. 2008 May;101(2):184-7
pubmed: 18215663
Am J Obstet Gynecol. 2018 May;218(5):514.e1-514.e8
pubmed: 29425837
Aust N Z J Obstet Gynaecol. 1994 Aug;34(4):471-4
pubmed: 7848244
Am J Obstet Gynecol. 2005 May;192(5):1592-8
pubmed: 15902163
Am J Obstet Gynecol. 2000 Jun;182(6):1610-5
pubmed: 10871485
Obstet Gynecol. 1998 Mar;91(3):364-8
pubmed: 9491861
Am J Obstet Gynecol. 2005 May;192(5):1573-7
pubmed: 15902160
JAMA. 2014 Mar 12;311(10):1023-34
pubmed: 24618964
Obstet Gynecol. 2018 Aug;132(2):298-309
pubmed: 29995735
Contemp Clin Trials. 2009 Mar;30(2):178-89
pubmed: 19130903
Obstet Gynecol. 1995 Dec;86(6):946-9
pubmed: 7501345
Int Urogynecol J. 2010 Apr;21(4):447-52
pubmed: 19960183